Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance

被引:68
作者
Das, Kalyan [1 ,2 ]
Bandwar, Rajiv P. [1 ,2 ]
White, Kirsten L. [3 ]
Feng, Joy Y. [3 ]
Sarafianos, Stefan G. [1 ,2 ]
Tuske, Steven [1 ,2 ]
Tu, Xiongying [1 ,2 ]
Clark, Arthur D., Jr. [1 ,2 ]
Boyer, Paul L. [4 ]
Hou, Xiaorong [2 ]
Gaffney, Barbara L. [2 ]
Jones, Roger A. [2 ]
Miller, Michael D. [3 ]
Hughes, Stephen H. [4 ]
Arnold, Eddy [1 ,2 ]
机构
[1] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
[3] Gilead Sci Inc, Foster City, CA 94404 USA
[4] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; THYMIDINE ANALOG MUTATIONS; IN-VITRO SELECTION; MOLECULAR-MECHANISMS; PRIMER UNBLOCKING; NUCLEOSIDE ANALOG; COMBINATION THERAPY; DRUG-RESISTANCE; AZT RESISTANCE; DNA;
D O I
10.1074/jbc.M109.022525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
K65R is a primary reverse transcriptase (RT) mutation selected in human immunodeficiency virus type 1-infected patients taking antiretroviral regimens containing tenofovir disoproxil fumarate or other nucleoside analog RT drugs. We determined the crystal structures of K65R mutant RT crosslinked to double-stranded DNA and in complexes with tenofovir diphosphate (TFV-DP) or dATP. The crystals permit substitution of TFV-DP with dATP at the dNTP-binding site. The guanidinium planes of the arginines K65R and Arg72 were stacked to form a molecular platform that restricts the conformational adaptability of both of the residues, which explains the negative effects of the K65R mutation on nucleotide incorporation and on excision. Furthermore, the guanidinium planes of K65R and Arg72 were stacked in two different rotameric conformations in TFV-DP- and dATP-bound structures that may help explain how K65R RT discriminates the drug from substrates. These K65R-mediated effects on RT structure and function help us to visualize the complex interaction with other key nucleotide RT drug resistance mutations, such as M184V, L74V, and thymidine analog resistance mutations.
引用
收藏
页码:35092 / 35100
页数:9
相关论文
共 54 条
[41]   Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an α-boranophosphate nucleoside analogue [J].
Selmi, B ;
Boretto, J ;
Sarfati, SR ;
Guerreiro, C ;
Canard, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :48466-48472
[42]  
Shahs FS, 2000, J BIOL CHEM, V275, P27037
[43]   Replication-dependent 65R→K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R+L74V [J].
Sharma, PL ;
Nurpeisov, V ;
Lee, K ;
Skaggs, S ;
Filippo, CAD ;
Schinazi, RF .
VIROLOGY, 2004, 321 (02) :222-234
[44]   Mutational analysis of Lys65 of HIV-1 reverse transcriptase [J].
Sluis-Cremer, N ;
Arion, D ;
Kaushik, N ;
Lim, H ;
Parniak, MA .
BIOCHEMICAL JOURNAL, 2000, 348 :77-82
[45]   Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors [J].
Sluis-Cremer, Nicolas ;
Sheen, Chih-Wei ;
Zelina, Shannon ;
Torres, Pedro S. Argoti ;
Parikh, Urvi A. ;
Mellors, John W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) :48-53
[46]   The A62V and S68G mutations in HIV-1 reverse transcriptase partially restore the replication defect associated with the K65R mutation [J].
Svarovskaia, Evguenia S. ;
Feng, Joy Y. ;
Margot, Nicolas A. ;
Myrick, Florence ;
Goodman, Derrick ;
Ly, John K. ;
White, Kirsten L. ;
Kutty, Nilima ;
Wang, Ruth ;
Borroto-Esoda, Katyna ;
Miller, Michael D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (04) :428-436
[47]   RAPID INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-THIACYTIDINE INHIBITORS DUE TO A MUTATION IN THE YMDD REGION OF REVERSE-TRANSCRIPTASE [J].
TISDALE, M ;
KEMP, SD ;
PARRY, NR ;
LARDER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5653-5656
[48]   Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir [J].
Tuske, S ;
Sarafianos, SG ;
Clark, AD ;
Ding, JP ;
Naeger, LK ;
White, KL ;
Miller, MD ;
Gibbs, CS ;
Boyer, PL ;
Clark, P ;
Wang, G ;
Gaffney, BL ;
Jones, RA ;
Jerina, DM ;
Hughes, SH ;
Arnold, E .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (05) :469-474
[49]   Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates [J].
Whitcomb, JM ;
Parkin, NT ;
Chappey, C ;
Hellmann, NS ;
Petropoulos, CJ .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07) :992-1000
[50]  
White KL, 2006, ANTIVIR THER, V11, P155